Qu Biologics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 17

Qu Biologics General Information

Description

Developer of a site-specific immunotherapy platform designed to restore the body's normal immune function to treat cancer and other immune-related diseases. The company's immunotherapy utilizes built-in knowledge to direct an activated innate immune response to specific organs or tissues to respond productively to any pathology that may be present at that body site, enabling medical researchers to develop a therapy that can activate and train the human immune system to fight cancer and other diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 4475 Wayburne Drive
  • Suite 305
  • Burnaby, British Columbia V5G 4X4
  • Canada
+1 (604)
Primary Industry
Drug Discovery
Corporate Office
  • 4475 Wayburne Drive
  • Suite 305
  • Burnaby, British Columbia V5G 4X4
  • Canada
+1 (604)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qu Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Qu Biologics‘s full profile, request access.

Request a free trial

Qu Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a site-specific immunotherapy platform designed to restore the body's normal immune function to treat cance
Drug Discovery
Burnaby, Canada
11 As of 2026

Plymouth Meeting, PA
 

Port Coquitlam, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Qu Biologics Competitors (26)

One of Qu Biologics’s 26 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Novation Pharmaceuticals Corporation Port Coquitlam, Canada
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
Centrose Venture Capital-Backed Madison, WI
Kite Pharma Formerly VC-backed Santa Monica, CA
You’re viewing 5 of 26 competitors. Get the full list »

Qu Biologics Patents

Qu Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025222288-A1 Immunomodulatory control of metabolic dysregulation Pending 23-Apr-2024
AU-2022246300-A1 Perioperative innate immune priming in cancer therapy Pending 24-Mar-2021
CA-3212380-A1 Perioperative innate immune priming in cancer therapy Pending 24-Mar-2021
EP-4313176-A1 Perioperative innate immune priming in cancer therapy Pending 24-Mar-2021
EP-4313176-A4 Perioperative innate immune priming in cancer therapy Pending 24-Mar-2021 A61K35/74
To view Qu Biologics’s complete patent history, request access »

Qu Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qu Biologics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Qu Biologics‘s full profile, request access.

Request a free trial

Qu Biologics FAQs

  • When was Qu Biologics founded?

    Qu Biologics was founded in 2007.

  • Where is Qu Biologics headquartered?

    Qu Biologics is headquartered in Burnaby, Canada.

  • What is the size of Qu Biologics?

    Qu Biologics has 11 total employees.

  • What industry is Qu Biologics in?

    Qu Biologics’s primary industry is Drug Discovery.

  • Is Qu Biologics a private or public company?

    Qu Biologics is a Private company.

  • What is Qu Biologics’s current revenue?

    The current revenue for Qu Biologics is .

  • How much funding has Qu Biologics raised over time?

    Qu Biologics has raised $65.2M.

  • Who are Qu Biologics’s investors?

    Canadian Institutes of Health Research, NRC-IRAP, Curitas Ventures, Harmonix Fund, and Felicity Global Capital are 5 of 6 investors who have invested in Qu Biologics.

  • Who are Qu Biologics’s competitors?

    Inovio Pharmaceuticals, Novation Pharmaceuticals, Cellaion, Centrose, and Kite Pharma are some of the 26 competitors of Qu Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process